Endurance training in patients with schizophrenia and healthy controls: differences and similarities

Imagem de Miniatura
Arquivos
art_KELLER-VARADY_Endurance_training_in_patients_with_schizophrenia_and_healthy_2016.PDF (541.59 KB)
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2016
Editora
SPRINGER HEIDELBERG
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
KELLER-VARADY, Katriona
HASAN, Alkomiet
SCHNEIDER-AXMANN, Thomas
HILLMER-VOGEL, Ursula
ADOMSSENT, Bjoern
WOBROCK, Thomas
NIKLAS, Andree
FALKAI, Peter
MALCHOW, Berend
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v.266, n.5, p.461-473, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aims were to examine the feasibility of and adaptations to endurance training in persons diagnosed with schizophrenia and to address the question whether the principles and beneficial effects of endurance training established in the healthy population apply also to patients with schizophrenia. In this controlled interventional study, 22 patients with schizophrenia and 22 healthy controls performed a standardized aerobic endurance training on bicycle ergometers over 12 weeks. Another group of 21 patients with schizophrenia played table soccer. Endurance capacity was measured with incremental cycle ergometry before and after the intervention and 3 months later. A specific set of outcome parameters was defined. The training stimuli can be assumed to be similar in both endurance groups. Endurance capacity improved significantly in the endurance groups, but not in the table soccer group. Patients and healthy controls showed comparable adaptations to endurance training, as assessed by physical working capacity and maximal achieved power. Differences were found in changes of performance at a lactate concentration of 3 mmol/l. Endurance training was feasible and effective in both groups. The principles and types of training that are usually applied to healthy controls need to be verified in patients with schizophrenia. Nevertheless, patients benefited from endurance training in terms of improvement of endurance capacity and reduction in the baseline deficit in comparison with healthy controls. Therefore, endurance training should be implemented in future therapy programs. These programs need to pay special attention to the differences between patients with schizophrenia and healthy controls.
Palavras-chave
Adaptations, Endurance, Sports therapy, Psychiatry, Schizophrenia, Exercise
URI
https://observatorio.fm.usp.br/handle/OPI/16505
Referências
  1. Abdel-Baki A, 2013, SCHIZOPHR RES, V149, P112, DOI 10.1016/j.schres.2013.06.040
  2. Antonovsky A., 1979, HLTH STRESS COPING N
  3. Bagger M, 2003, INT J SPORTS MED, V24, P433
  4. Beebe LH, 2013, ISSUES MENT HEALTH N, V34, P214, DOI 10.3109/01612840.2012.746411
  5. Bernard P, 2013, SCI SPORT, V28, P247, DOI 10.1016/j.scispo.2013.02.005
  6. Borg G A, 1974, Exerc Sport Sci Rev, V2, P131
  7. Bredin Shannon S D, 2013, Brain Sci, V3, P821, DOI 10.3390/brainsci3020821
  8. Chen EYH, 2012, SCHIZOPHR RES, V136, pS56
  9. De Hert M, 2011, WORLD PSYCHIATRY, V10, P52
  10. Deimel H, 1983, Rehabilitation (Stuttg), V22, P81
  11. Dodd KJ, 2011, DISABIL REHABIL, V33, P1222, DOI 10.3109/09638288.2010.526162
  12. Deutsches Institut fur Medizinische Dokumentation und Information, 2013, ICD 10 GM VERS 2014
  13. Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108
  14. Falkai P, 2014, FORTSCHR NEUROL PSYC, V82, P186, DOI 10.1055/s-0033-1355935
  15. Falkai P, 2013, EUR ARCH PSY CLIN N, V263, P469, DOI 10.1007/s00406-012-0383-y
  16. Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149
  17. Firth J, 2015, PSYCHOL MED, V45, P1343, DOI 10.1017/S0033291714003110
  18. Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
  19. Hasnain M, 2011, ACTA PSYCHIAT SCAND, V123, P409, DOI 10.1111/j.1600-0447.2011.01676.x
  20. Heggelund J, 2011, NORD J PSYCHIAT, V65, P269, DOI 10.3109/08039488.2011.560278
  21. Herbsleb Marco, 2014, Front Psychiatry, V5, P119, DOI 10.3389/fpsyt.2014.00119
  22. Heyn PC, 2008, J NUTR HEALTH AGING, V12, P401, DOI 10.1007/BF02982674
  23. HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.1093/biomet/75.2.383
  24. Hottenrott K, 2014, LEHRBUCH 14 LEKTIONE
  25. Josefsson T, 2014, SCAND J MED SCI SPOR, V24, P259, DOI 10.1111/sms.12050
  26. KATCH VL, 1982, MED SCI SPORT EXER, V14, P21, DOI 10.1249/00005768-198201000-00004
  27. Kerling A, 2013, PSYCHIAT QUART, V84, P417, DOI 10.1007/s11126-013-9256-4
  28. Kim HJ, 2014, PSYCHIAT RES, V220, P792, DOI 10.1016/j.psychres.2014.09.020
  29. Kimhy D, 2015, SCHIZOPHRENIA BULL, V41, P859, DOI 10.1093/schbul/sbv022
  30. Kutzner I, 2012, J ORTHOP SPORT PHYS, V42, P1032, DOI 10.2519/jospt.2012.4001
  31. Leone M, 2015, SCHIZOPHR RES, V164, P270, DOI 10.1016/j.schres.2015.03.002
  32. Malchow B, 2013, EUR ARCH PSY CLIN N, V263, P451, DOI 10.1007/s00406-013-0423-2
  33. Malchow B, 2016, SCHIZOPHR RES, V173, P182, DOI 10.1016/j.schres.2015.01.005
  34. Malchow B, 2015, SCHIZOPHRENIA BULL, V41, P847, DOI 10.1093/schbul/sbv020
  35. Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x
  36. Marzolini S, 2009, MENT HEALTH PHYS ACT, V2, P29, DOI [10.1016/j.mhpa.208.1.01, DOI 10.1016/J.MHPA.2008.11.001]
  37. Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002
  38. Nilsson BM, 2012, EUR PSYCHIAT, V27, P206, DOI 10.1016/j.eurpsy.2010.06.007
  39. Oertel-Knochel V, 2014, EUR ARCH PSY CLIN N, V264, P589, DOI 10.1007/s00406-014-0485-9
  40. Ostermann S, 2013, SCHIZOPHRENIA BULL, V39, P1139, DOI 10.1093/schbul/sbs085
  41. Ozbulut O, 2013, PSYCHIAT RES, V210, P806, DOI 10.1016/j.psychres.2013.09.015
  42. Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193
  43. Park C, 2012, MOL CELLS, V33, P105, DOI 10.1007/s10059-012-2284-3
  44. Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107
  45. Pfitzinger P, 1998, INT J SPORTS MED, V19, P349, DOI 10.1055/s-2007-971929
  46. Regenold WT, 2009, BIOL PSYCHIAT, V65, P489, DOI 10.1016/j.biopsych.2008.11.010
  47. Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000
  48. Rosenbaum S, 2015, PSYCHIAT RES-NEUROIM, V232, P200, DOI 10.1016/j.pscychresns.2015.02.004
  49. Rosenbaum S, 2014, J CLIN PSYCHIAT, V75, P964, DOI 10.4088/JCP.13r08765
  50. Scharhag-Rosenberger F, 2013, DEUT Z SPORTMED, V64, P362
  51. Scharhag-Rosenberger F, 2010, J SCI MED SPORT, V13, P74, DOI 10.1016/j.jsams.2008.12.626
  52. Scheewe TW, 2013, EUR NEUROPSYCHOPHARM, V23, P675, DOI 10.1016/j.euroneuro.2012.08.008
  53. Scheewe TW, 2012, MED SCI SPORT EXER, V44, P1834, DOI 10.1249/MSS.0b013e318258e120
  54. SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545
  55. Soundy A, 2014, PSYCHIAT SERV, V65, P693, DOI 10.1176/appi.ps.201300276
  56. Srihari VH, 2013, SCHIZOPHR RES, V146, P64, DOI 10.1016/j.schres.2013.01.014
  57. Stathopoulou G, 2006, CLIN PSYCHOL-SCI PR, V13, P179, DOI 10.1111/j.1468-2850.2006.00021.x
  58. Steinacker J. M., 2002, Deutsche Zeitschrift fuer Sportmedizin, V53, P228
  59. Strassnig MT, 2012, SCHIZOPHR RES, V141, P284, DOI 10.1016/j.schres.2012.08.011
  60. Stubbs B, 2014, BRIT J PSYCHIAT, V204, P164, DOI 10.1192/bjp.204.2.164
  61. Svatkova A, 2015, SCHIZOPHRENIA BULL, V41, P869, DOI 10.1093/schbul/sbv033
  62. Taylor ED, 2006, PEDIATRICS, V117, P2167, DOI 10.1542/peds.2005-1832
  63. Vancampfort D, 2015, ACTA PSYCHIAT SCAND, V132, P131, DOI 10.1111/acps.12407
  64. Vancampfort D, 2011, ACTA PSYCHIAT SCAND, V123, P423, DOI 10.1111/j.1600-0447.2010.01666.x
  65. Vancampfort D, 2015, COMPR PSYCHIAT, V56, P128, DOI 10.1016/j.comppsych.2014.10.007
  66. Wichniak A, 2011, J PSYCHIATR RES, V45, P1381, DOI 10.1016/j.jpsychires.2011.05.009

Coleções
Artigos e Materiais de Revistas Científicas - LIM/27